Institutional Ownership
Nektar Therapeutics
CUSIP 640268108COMNKTRQ1 2026
13D / 13G Filings
50
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
9
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
50 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Tcg Crossover Gp II, LLC | 13G/A | 11.0% | 9 | SEC |
| 2 | Aug 14, 2025 | Tcg Crossover Gp II, LLC | 13G/A | 11.0% | 1.93M | SEC |
| 3 | May 15, 2025 | Samlyn Capital, LLC | 13G/A | — | — | SEC |
| 4 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 6.7% | 12.53M | SEC |
| 5 | Feb 14, 2025 | Eventide Asset Management, LLC | 13G/A | 3.6% | — | SEC |
| 6 | Feb 14, 2025 | Deep Track Capital, LP | 13G/A | 1.1% | 1.98M | SEC |
| 7 | Feb 14, 2025 | Samlyn Capital, LLC | 13G | 5.2% | — | SEC |
| 8 | Nov 14, 2024 | Eventide Asset Management, LLC | 13G | 5.1% | 9.40M | SEC |
| 9 | Nov 14, 2024 | Deep Track Capital, LP | 13G/A | 8.7% | 15.92M | SEC |
| 10 | Nov 8, 2024 | Blackrock, Inc. | 13G | 8.7% | 15.97M | SEC |
40 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Nektar Therapeutics.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Parallel Advisors, LLC | 1.1K | $75.8K |
| 2 | Eversource Wealth Advisors, LLC | 111 | $8.0K |
| 3 | Hollencrest Capital Management | 60 | $4.3K |
| 4 | Fortitude Family Office, LLC | 7 | $504 |
| 5 | Twin Peaks Wealth Advisors, LLC | 5 | $384 |
| 6 | Farther Finance Advisors, LLC | 1 | $76 |
| 7 | Root Financial Partners, LLC | 1 | $72 |
| 8 | Lri Investments, LLC | 1 | $72 |
| 9 | Huntington National Bank | 1 | $1 |